Russia is ready to conduct clinical trials in Ukraine of a COVID-19 vaccine combining its Sputnik V with a vaccine developed by AstraZeneca together with Oxford University, the head of Russian Direct Investment Fund (RDIF) said on Saturday.
Russia’s sovereign RDIF, which is marketing the Sputnik V vaccine abroad, announced in December trials to test a combination of the AstraZeneca vaccine with the Sputnik V shot to see if this can boost the efficacy of the British drugmaker’s vaccine.
Russia reported 26,301 coronavirus cases over the past 24 hours, the country’s anti-coronavirus crisis center said on Saturday.
The new cases bring Russia's tally of confirmed COVID-19 cases up to 3,212,637, state news agency TASS reported.
In another development, Britain will allow people to be given shots of different COVID-19 vaccines on rare occasions, despite a lack of evidence about the extent of immunity offered by mixing doses.
In a departure from other strategies globally, the government said people could be given a mix-and-match of two COVID-19 shots, for example if the same vaccine dose was out of stock, according to guidelines published on New Year’s Eve.
Coronavirus: Hungary receives 6,000 doses of Russia’s Sputnik V COVID-19 vaccineHungary has received 6,000 doses of Russia’s COVID-19 vaccine, Foreign Minister Peter Szijjarto said on his Facebook page on Monday, though it was ... Coronavirus
Coronavirus: First 300,000 doses of Russia's Sputnik vaccine arrive in ArgentinaSome 300,000 doses of Russia's Sputnik V COVID-19 vaccine arrived in Argentina on Thursday morning, following its approval by the government for ... Coronavirus
Coronavirus: AstraZeneca expects to supply 2 mln doses of vaccine every week in UKAbout two million doses of COVID-19 vaccine developed by Oxford University and AstraZeneca are set to be supplied every week by the middle of January ... Coronavirus